• Profile

Management of type-I gastric neuroendocrine neoplasms: A 10-years prospective single center study

Digestive and Liver Diseases Dec 15, 2021

Esposito G, Cazzato M, Rinzivillo M, et al. - The outcomes of patients with type 1 gastric neuroendocrine neoplasia (T1gNENs), receiving treatments with different endoscopic approaches, were analyzed.

  • Endoscopic surveillance was performed at regular intervals to manage the patients.

  • Forceps or cold snare were used to perform resection in tumors < 10 mm, otherwise mucosal resection (EMR) or submucosal dissection (ESD) were conducted.

  • Researchers included 127 T1gNENs identified in 80 patients; 87.4% of these were < 5 mm, whereas 8.7% were 6–10 mm, 3.1% were 11–20 mm, and 0.8% was > 20 mm.

  • Outcomes suggest that based on tumor size, the management of T1gNENs may be planned.

  • Follow-up using noninterventional endoscopic surveillance could be done in cases with T1gNENs < 5 mm for which the initial removal is not radical.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen